🟢 Cue Biopharma is trading 11% up with no identified company-specific catalyst

Cue Biopharma is trading 11.00% up at $20.34 on October 28, 2026, with no identified company-specific announcement explaining the move.

• Recent coverage remains focused on September’s CUE-221 Phase 2 results.
• Biotech’s reported 2.18% gain offers a supportive sector backdrop but does not establish the cause of Cue Biopharma’s larger rise.